1-20 of 48
Francesco Lanza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The use of danicopan as an add-on therapy in a ravulizumab-treated adult patient with paroxysmal nocturnal hemoglobinuria (PNH) and concomitant stage IV renal failure has induced a marked improvement of anemia and of clinically significant extravascular hemolysis in absence of deterioration of renal function

Free
Francesco Lanza, Barbara Castagnari, Claudia Cellini, Evita Massari, Martina Cantelli, Giovanni Marconi
Journal: Blood
Blood (2025) 146 (Supplement 1): 6446.
https://doi.org/10.1182/blood-2025-6446
Published: 2025
Journal Articles

Real world use of sutimlimab in patients with cold agglutinin disease: An international study

Free
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco, Michael Fillitz, George Kannourakis, Maria Bruna Greve, Moritz Kleemiss, Joan Cid, Andrea Patriarca, Laura Pavan, Arbana Dizdari, Nilla Maschio, Antonella Sau, Cinzia Bitetti, Luigi Curreli, Dorela Lame, Uros Markovic, Antonio Solimando, Giacinto Luca Pedone, Francesco Versino, Marta Bortolotti, Davide Rapezzi, Vincenzo Sammartano, Nicola Tumedei, Luana Fianchi, Jahanzaib Khwaja, Antonio De Vivo, Francesco Lanza, Fabrizio Vianello, Esther Natalie Oliva, Ulrich Jaeger, Bernd Jilma, Guillaume Moulis, Wilma Barcellini
Journal: Blood
Blood (2025) 146 (Supplement 1): 1100.
https://doi.org/10.1182/blood-2025-1100
Published: 2025
Journal Articles

Crenolanib plus salvage chemotherapy improves outcomes in FLT3-mutant and NPM1 co-mutated relapsed/ refractory (R/R) Acute Myeloid Leukemia (AML): Results from a randomized, placebo-controlled, double-blind trial

Free
Thomas Cluzeau, Pierre Yves Dumas, Pau Montesinos, Gaia Ciolli, Céline Berthon, Felicetto Ferrara, Adriano Venditti, José Antonio Pérez-Simón, Maria Calbacho, Richard Noppeney, Monia Lunghi, Chiara Cattaneo, Fabrizio Pane, Francesco Lanza, Juan Miguel Bergua Burgues, Alessandro Isidori, Yngvar Floisand, Vinay Jain, Eunice Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 767.
https://doi.org/10.1182/blood-2025-767
Published: 2025
Journal Articles

Prognostic relevance of mutational profile in secondary Acute Myeloid Leukemia patients treated with CPX-351.

Free
Carola Riva, Paola Minetto, Giovanni Marconi, Giada Zecchetti, Stefano Nicoletta, Michela Rondoni, Roberta Romei, Ylenia Azzanelli, Nicoletta Colombo, Sara Rosellini, Alessia Parodi, Elisabetta Tedone, Enrico Carminati, Francesco Puglisi, Clara Nurra, Giuseppina Fugazza, Paolo Nozza, Michele Cea, Francesco Lanza, Roberto Lemoli, Fabio Guolo
Journal: Blood
Blood (2025) 146 (Supplement 1): 1623.
https://doi.org/10.1182/blood-2025-1623
Published: 2025
Journal Articles

Reaction - Real Life Use of Ravulizumab in Italian Patients with Paroxysmal Nocturnal Hemoglobinuria a Multicenter Observational Retrospective and Prospective Cohort Study, Final Results

Free
Bruno Fattizzo, Anna Paola Iori, Antonio De Vivo, Elisabetta Metafuni, Amalia Figuera, Luana Marano, Esther Natalie Oliva, Maria Bruna Greve, Francesco Lanza, Eros Di Bona, Jacopo Micozzi, Giovanni Caocci, Francesca Fioritoni, Fabio Ciceri, Angela Amendola, Carmine Selleri, Francesco Longu, Alessandra Tucci, Eloise Beggiato, Davide Rapezzi, Alessandro Cignetti, Tiziana Anna Urbano, Nicola Di Renzo, Valeria Amico, Pierangelo Spedini, Alessandro Rambaldi, Simona Raso, Cristina Clissa, Sergio Cabibbo, Barbara Roncari, Lucia Simoni, Benedetta Campolo, Fabio Carini, Davide Mattiuzzi, Wilma Barcellini
Journal: Blood
Blood (2024) 144 (Supplement 1): 2464.
https://doi.org/10.1182/blood-2024-204659
Published: 2024
Journal Articles

Centralized MRD Assessment in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax Combined with Intensified FLAI Chemotherapy (V-FLAI) As Induction Therapy of Non Low-Risk AML

Free
Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Giovanni Marsili, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto Massimo Lemoli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2024-198139
Published: 2024
Journal Articles

Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial

Free
Daniel J. DeAngelo, Andre C. Schuh, Brian A. Jonas, Pamela S. Becker, Anjali S. Advani, Geoffrey L. Uy, Janusz Krawczyk, Harry P. Erba, Gabriel N Mannis, Chun Yew Fong, Florian Kuchenbauer, Mary-Elizabeth M. Percival, Jane L. Liesveld, William Blum, Brenda W Cooper, Alice Mims, Francesco Lanza, Jeroen J.W.M. Janssen, Juan Miguel Bergua Burgues, Tibor Kovacsovics, Norbert Vey, Martina V. Hemmer, Gaetano Bonifacio, Edwin Rock, Pau Montesinos
Journal: Blood
Blood (2024) 144 (Supplement 1): 733.
https://doi.org/10.1182/blood-2024-209097
Published: 2024
Journal Articles

Applicability of SIE/Sies/GITMO Fitness Criteria to Therapy-Related and AML-MRC Receiving CPX-351: Results from a Large, Retrospective, Multicentric, Observational Study

Free
Raffaele Palmieri, Fabio Guolo, Luana Fianchi, Felicetto Ferrara, Maria Paola Martelli, Michela Rondoni, Capria Saveria, Paola Minetto, Clara Minotti, Sofia Sciabolacci, Federica Pilo, Salvatore Perrone, Andrea Corbingi, Francesco Grimaldi, Giulia De Luca, Carla Fili, Caterina Alati, Francesco Mannelli, Federica Lessi, Francesco Marchesi, Lorenzo Brunetti, Debora Capelli, Anna Lina Piccioni, Calogero Vetro, Carla Mazzone, Alessandra Sperotto, Giovanni Luzi, Michelina Dargenio, Sabrina Mariani, Marco Cerrano, Antonino Mulè, Ambra Di Veroli, Cristina Papayannidis, Alessandro Isidori, Francesco Lanza, Michele Gottardi, Elisabetta Todisco, Livio Pagano, Roberto Massimo Lemoli, Francesco Buccisano, Adriano Venditti
Journal: Blood
Blood (2023) 142 (Supplement 1): 2891.
https://doi.org/10.1182/blood-2023-181142
Published: 2023
Journal Articles

CNS Prophylaxis in Adult ALL Patients after Stem Cell Transplantation: An EBMT Survey on General Practice

Free
Patrizia Chiusolo, Myriam Labopin, Irma Khvedelidze, Frederic Baron, Eolia Brissot, Ali Bazarbachi, Gesine Bug, Jordi Esteve, Sebastian Giebel, Norbert Claude Gorin, Zina Peric, Francesco Lanza, Arnon Nagler, Simona Piemontese, Annalisa Ruggeri, Jaime Sanz, Bipin N. Savani, Christoph Schmidt, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2023) 142 (Supplement 1): 7049.
https://doi.org/10.1182/blood-2023-182831
Published: 2023
Journal Articles

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Free
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia MC Langemeijer, Satheesh Chonat, Jia Cao, Vincent Chow, Haby Henary
Journal: Blood
Blood (2023) 142 (Supplement 1): 4092.
https://doi.org/10.1182/blood-2023-186362
Published: 2023
Journal Articles

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Free
Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paola Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto M. Lemoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1567.
https://doi.org/10.1182/blood-2023-189777
Published: 2023
Journal Articles

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Free
Michela Rondoni, Paola Minetto, Bruna Puglisi, Francesco Saraceni, Lorenzo Brunetti, Anna Maria Mianulli, Monica Bocchia, Adele Santoni, Carola Riva, Barbara Giannini, Federica Monaco, Beatrice Zannetti, Claudia Cellini, Annalisa Nicoletti, Anna Maria Valenti, Debora Capelli, Donatella Raspadori, Attilio Olivieri, Francesco Lanza, Claudio Graziano, Patrizia Tosi, Roberto Massimo Lemoli, Fabio Guolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 4275.
https://doi.org/10.1182/blood-2023-182993
Published: 2023
Journal Articles

Practice Patterns of Transplant Centers Regarding Maintenance Treatment Post Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Survey on Behalf of the EBMT Acute Leukemia Working Party

Free
Iman Abou Dalle, Myriam Labopin, Irma Khvedelidze, Frederic Baron, Eolia Brissot, Gesine Bug, Jordi Esteve, Sebastian Giebel, Norbert Claude Gorin, Francesco Lanza, Arnon Nagler, Zina Peric, Simona Piemontese, Annalisa Ruggeri, Jaime Sanz, Bipin N. Savani, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 7089.
https://doi.org/10.1182/blood-2023-187095
Published: 2023
Journal Articles

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Free
Clinical Trials & Observations
Guido Gini, Monica Tani, Alessandra Tucci, Luigi Marcheselli, Marina Cesaretti, Monica Bellei, Anna Pascarella, Filippo Ballerini, Mauro Petrini, Francesco Merli, Attilio Olivieri, Francesco Lanza, Ombretta Annibali, Vittorio Ruggero Zilioli, Anna Marina Liberati, Maria Chiara Tisi, Annalisa Arcari, Dario Marino, Gerardo Musuraca, Vincenzo Pavone, Alberto Fabbri, Samantha Pozzi, Donato Mannina, Caterina Plenteda, Melania Celli, Stefano Luminari
Journal: Blood
Blood (2023) 142 (17): 1438–1447.
https://doi.org/10.1182/blood.2022019173
Published: 2023
Includes: Supplemental data
Journal Articles

Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Free
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Roberto Massimo Lemoli, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo G. Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Fabio Guolo, Edoardo La Sala, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 1705–1707.
https://doi.org/10.1182/blood-2022-157393
Published: 2022
Journal Articles

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Free
Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary
Journal: Blood
Blood (2022) 140 (Supplement 1): 8660–8662.
https://doi.org/10.1182/blood-2022-166722
Published: 2022
Journal Articles

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Free
Marcos J.G. de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Michael T Hemmer, Mei-Jie Zhang, Fan Zhang, Richa Shah, Verna Welch, Saara Tikka, Erik Vandendries, Matthias Stelljes, David I. Marks, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 6023–6025.
https://doi.org/10.1182/blood-2022-160315
Published: 2022
Journal Articles

INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Free
Cristina Papayannidis, Patrizia Zappasodi, Nicola S Fracchiolla, Francesco Di Raimondo, Daniele Giovanni Mattei, Francesco Lanza, Endri Mauro, Maria Ilaria Del Principe, Erika Borlenghi, Monica Fumagalli, Elisabetta Todisco, Simona Sica, Nicola Di Renzo, Paolo De Fabritiis, Paolo Corradini, Daniele Vallisa, Fara Petruzziello, Mario Luppi, Fabrizio Pane, Felicetto Ferrara, Francesco Passamonti, Antonino Mulè, Chiara Zingaretti, Giovanni Marconi, Irene Valli, Elisabetta Petracci, Alberto Clemente, Giuseppe Nicola Saglio, Fabio Ciceri, Giovanni Martinelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2021-149157
Published: 2021
Journal Articles

Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia

Free
Adriano Venditti, Alfonso Piciocchi, Raffaele Palmieri, Valentina Arena, Anna Candoni, Valeria Calafiore, Lorella MA Melillo, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Elisa Buzzatti, Maria Teresa Voso, Tiziana Ottone, Maria irno Consalvo, Paola Fazi, Marco Vignetti, William Arcese, Sergio Amadori, Francesco Buccisano
Journal: Blood
Blood (2021) 138 (Supplement 1): 2359.
https://doi.org/10.1182/blood-2021-147200
Published: 2021
Journal Articles

Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia

Free
Jorge E. Cortes, Jordi Esteve, Ashish Bajel, Karen Yee, Thorsten Braun, Stephane De Botton, Pierre Peterlin, Christian Recher, Xavier Thomas, Justin Watts, Montserrat Arnan Sangerman, Antonio Curti, Carolyn Grove, Brian A. Jonas, Francesco Lanza, Olivier Legrand, Pau Montesinos, Prapti Patel, Thomas Prebet, Eunice S. Wang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Pierre Fenaux, Andrew H. Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 698.
https://doi.org/10.1182/blood-2021-144905
Published: 2021